(Q81311020)
Statements
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer (English)
Ronald M Bukowski
Fairooz F Kabbinavar
Robert A Figlin
Keith Flaherty
Sandy Srinivas
Ulka Vaishampayan
Harry A Drabkin
Sarah Ryba
Qi Xia
Frank A Scappaticci
David McDermott
17 September 2007